Journal article

Comparison of two schedules of two-dose priming with the ten-valent pneumococcal conjugate vaccine in Nepalese children: an open-label, randomised non-inferiority controlled trial

Abstract:: Background

Nepalese infants receive ten-valent pneumococcal conjugate vaccine (PCV10) with a 1 month interval between priming doses for programmatic reasons. We aimed to investigate whether immune responses to PCV10 serotypes were non-inferior if the second priming dose of PCV10 was delivered at a 1 month interval as opposed to a 2 month interval.

Methods

We did an open-label, randomised, parallel group trial in healthy Nepalese infants aged 40–60 days at Patan Hospita...
Expand abstract
Collapse abstract

Publication status:: Published

Peer review status:: Peer reviewed

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

Kandasamy, R., Gurung, M., Thorson, S., Yu, L., Galal, U., Voysey, M., Kelly, S., Wahl, B., Berbers, G., Finnegan, K., Ansari, I., Paudel, K., Murdoch, D., O'Brien, K., Kelly, D., Goldblatt, D., Shrestha, S., & Pollard, A. (2019). Comparison of two schedules of two-dose priming with the ten-valent pneumococcal conjugate vaccine in Nepalese children: an open-label, randomised non-inferiority controlled trial. Lancet: Infectious Diseases, 19(2), 156–164.

MLA Style

Kandasamy, R., et al. “Comparison of Two Schedules of Two-Dose Priming with the Ten-Valent Pneumococcal Conjugate Vaccine in Nepalese Children: An Open-Label, Randomised Non-Inferiority Controlled Trial.” Lancet: Infectious Diseases, vol. 19, no. 2, 2019, pp. 156–64.

Chicago Style

Kandasamy, R., M. Gurung, S. Thorson, et al. 2019. “Comparison of Two Schedules of Two-Dose Priming with the Ten-Valent Pneumococcal Conjugate Vaccine in Nepalese Children: An Open-Label, Randomised Non-Inferiority Controlled Trial.” Lancet: Infectious Diseases 19 (2): 156–64.
Print

Access Document

Publisher copy:: 10.1016/s1473-3099(18)30568-1

Authors

+ Kandasamy, R More by this author

Institution:: University of Oxford
Division:: Medical Sciences Division
Department:: Department of Paediatrics
Role:: Author

+ Gurung, M More by this author

Role:: Author

+ Thorson, S More by this author

Role:: Author

+ Yu, LM More by this author

Institution:: University of Oxford
Division:: Medical Sciences Division
Department:: Primary Care Health Sciences
Role:: Author

+ Galal, U More by this author

Institution:: University of Oxford
Division:: Medical Sciences Division
Department:: Primary Care Health Sciences
Role:: Author

More authors...

Publisher:: Elsevier
Journal:: Lancet: Infectious Diseases More from this journal
Volume:: 19
Issue:: 2
Pages:: 156-164
Publication date:: 2019-01-08
Acceptance date:: 2018-09-11
DOI:: 10.1016/s1473-3099(18)30568-1
EISSN:: 1474-4457
ISSN:: 1473-3099
Pmid:: 30635252

Language:: English
Pubs id:: pubs:959581
UUID:: uuid:9c574e7e-817a-42b5-a2a9-1725227f2bc9
Local pid:: pubs:959581
Source identifiers:: 959581
Deposit date:: 2019-01-15
ARK identifier:: ark:/29072/ora_9c574e7e817a42b5a2a91725227f2bc9

Terms of use

Copyright holder:: Elsevier Ltd
Copyright date:: 2019
Notes:: © 2019 Elsevier Ltd. All rights reserved.

Licence:: Terms and Conditions of Use for Oxford University Research Archive

Views and Downloads

Views and downloads will return soon

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP